530697-BOM

The stock has been placed in Graded Surveillance Measure (GSM) list GSM - 0.

Zenlabs Ethica Ltd.

BSE: 530697

Sector: Services

Industry Group: Commercial Services & Supplies

Industry: Diversified Commercial Services

31.54+0.0 (+0.00%)

17 Jul, 10:29 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

20.53

P/E (TTM)

P/B

2.41

P/S (TTM)

0.44

EV/EBITDA

15.90

CAPE (5Y)

1494.79

ROE (TTM)

-20.44

ROCE (TTM)

4.18

ROA (TTM)

-4.97

Avg 3Y ROE

-4.52

Earnings 3Y CAGR

-81.22

Sales 3Y CAGR

-11.15

Sales 5Y CAGR

-3.69

Debt/Equity

1.29

Consensus TP

Strong Buy %

Promoter Holding

52.96

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Zenlabs Ethica Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Not enough talking points with positive stance

Negative

Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of -9.43% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Low and declining ROE

The company reported low ROE of -20.44% for 12-month ended 31 Mar 2026 and ROE declined by -2305 bps from 1 year ago

What is ROE (FY)?

Low but stable operating margin

The company reported low operating margin of 1.9% for 12-month ended 31 Mar 2026 and operating margin declined marginally by -63 bps from 1 year ago

What is Operating profit margin?

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of -8.75% for 12-month ended 31 Mar 2026 and the growth was 19.07 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 10.32

Value -8.75

-108.61342900

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -818.26% for 12-month ended 31 Mar 2026 and the growth was 821.88 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Reasonable Debt to Equity, and has been stable

The company has reasonable Debt to Equity of 1.29 as on 31 Mar 2026 and Debt to Equity increased marginally by 0.07 in the last 1 year

What is Debt to Equity?

Financial Snapshot

See detailed analysis

Multi-year trends for Zenlabs Ethica Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Zenlabs Ethica Ltd. Shareholding Pattern

Quarterly breakdown of Zenlabs Ethica Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	67.60	67.60	67.60	67.60	67.61	67.61	67.61	67.61	67.61	63.29	60.51	59.12	59.12	59.12	59.12	59.12	52.98	52.98	52.96	52.96	52.96	52.96	52.96	52.96	52.96
Indian Promoter	67.60	67.60	67.60	67.60	67.61	67.61	67.61	67.61	67.61	63.29	60.51	59.12	59.12	59.12	59.12	59.12	52.98	52.98	52.96	52.96	52.96	52.96	52.96	52.96	52.96
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	32.40	32.40	32.40	32.40	32.39	32.39	32.39	32.39	32.39	36.71	39.49	40.88	40.88	40.88	40.88	40.88	47.02	47.02	47.04	47.04	47.04	47.04	47.04	47.04	47.04
Bodies Corporate	-	1.06	0.48	0.56	0.66	-	1.24	1.76	1.33	0.84	0.50	0.66	0.70	0.50	0.66	1.08	0.69	0.77	1.60	1.50	1.58	1.52	1.63	1.20	1.27
Others (incl. Retail) No. of shareholders	32.40 1,010	31.34 1,020	31.92 1,091	31.84 1,160	31.73 1,181	32.39 1,356	31.15 1,474	30.63 1,603	31.06 1,969	35.87 1,991	38.99 1,993	40.22 2,016	40.18 1,941	40.38 2,004	40.22 2,137	39.80 2,175	46.33 2,461	46.25 2,438	45.44 2,609	45.54 2,605	45.46 2,639	45.52 2,624	45.41 2,684	45.84 2,749	45.77 2,728

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Zenlabs Ethica Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
Usha Jawaharlal Kalro	13 Mar 2026	sell	₹ 20.20	36.00 k	-
Kamal Kumar Goyal	15 Dec 2025	buy	₹ 22.03	40.00 k	-
Shyama Goyal	15 Dec 2025	sell	₹ 22.06	60.00 k	-
Rajesh Kumar	16 Jul 2025	sell	₹ 35.92	35.60 k	₹ 12.79 lac
Usha Jawaharlal Kalro	16 Jul 2025	buy	₹ 35.91	37.30 k	₹ 13.39 lac
Usha Jawaharlal Kalro	16 Jul 2025	sell	₹ 36.45	38.70 k	₹ 14.10 lac

Corporate Actions

History of Zenlabs Ethica Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Dividend₹ 0.25/share
Record date: 1st Aug 2022Ex-date: 29th Jul 2022
Announced on: 20th Jul 2022
Bonus1 new shares for 20 existing shares
Ex-date: 11th Oct 2018Announced on: 25th Aug 2018
Dividend₹ 0.25/share
Record date: 22nd Sep 2017Ex-date: 20th Sep 2017
Announced on: 30th Aug 2017

Company Profile

Overview of Zenlabs Ethica Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Zenlabs Ethica Limited is an India-based pharmaceutical contract manufacturing company. The Company develops, markets and exports a range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-bacterial Drugs, Nutraceuticals, and ...

Key personnel

Mr. Nikunj Goel

Compliance Officer, Company Secretary

Mr. Sanjeev KumarD

Chairman of the Board, Managing Director

Mr. Sanjay DhirD

Whole Time Director

Him JyotiD

Additional Director

Mr. Harpreet Singh KalraD

Additional Non-Executive Independent Director

Mr. Anurag MalhotraD

Additional Non-Executive Independent Director

Mr. Kuldeep SinghD

Additional Non-Executive Independent Director

Narang SinghD

Non-Executive Independent Director

Incorporated on

20 Jul 1993

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

20 Jul 1993

Free Float

21,98,659

Website

https://www.zenlabsethica.com/

Phone no.

+917307971103

Address

PLOT NO. 194-195, 3RD FLOOR, INDUSTRIAL AREA, PHASE II, RAM DARBAR, , 160002, India

Frequently Asked Questions

What is the current share price of Zenlabs Ethica Ltd.?

The current share price of Zenlabs Ethica Ltd. is ₹ 31.54 as of 17 Jul 2026.

What is the market capitalisation of Zenlabs Ethica Ltd.?

The market capitalisation of Zenlabs Ethica Ltd. stands at ₹ 20.53 Cr.

What is the PE ratio of Zenlabs Ethica Ltd.?

The Price-to-Earnings (PE) ratio of Zenlabs Ethica Ltd. is - as of the latest trailing twelve months data.

What is the ROE and ROCE of Zenlabs Ethica Ltd.?

Zenlabs Ethica Ltd. has a Return on Equity (ROE) of -20.44% and a Return on Capital Employed (ROCE) of 4.18% as per the latest financial reports.

What is the 52-week high and low of Zenlabs Ethica Ltd.?

The 52-week high of Zenlabs Ethica Ltd. is - and the 52-week low is -.

What is the dividend yield of Zenlabs Ethica Ltd.?

The dividend yield of Zenlabs Ethica Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Zenlabs Ethica Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 45.77% of Zenlabs Ethica Ltd. shares.

What sector does Zenlabs Ethica Ltd. belong to?

Zenlabs Ethica Ltd. operates in the Services sector.

What is the beta of Zenlabs Ethica Ltd.?

The beta of Zenlabs Ethica Ltd. is 1.09, indicating its price volatility relative to the broader market. Over the past 1 year, Zenlabs Ethica Ltd. has delivered an absolute return of -6.13%.

What is the RSI of Zenlabs Ethica Ltd.?

The 14-day Relative Strength Index (RSI) of Zenlabs Ethica Ltd. is 43.18, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Zenlabs Ethica Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Zenlabs Ethica Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Corporate Actions

Company Profile